# Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

> **NCT04040634** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 9476 (actual)

## Conditions studied

- Diabetes Mellitus
- High Blood Pressure
- Cardiovascular Diseases
- Cognitive Impairment

## Interventions

- **DRUG:** Intensive Control of Systolic Blood Pressure (SBP)
- **DRUG:** Standard control of Systolic Blood Pressure (SBP)

## Key facts

- **NCT ID:** NCT04040634
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-08
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 9476 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04040634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04040634, "Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04040634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*